ZARZA We are Zarza, the prestigious firm behind major projects in information technology.

Estimating the opportunity–cost-based cost–effectiveness threshold: a panel discussion

Future Science Group

22/04/2020 18 min

Estimating the opportunity–cost-based cost–effectiveness threshold: a panel discussion

Listen "Estimating the opportunity–cost-based cost–effectiveness threshold: a panel discussion"

Descargar episodio Ver en sitio original

Episode Synopsis

Estimating the opportunity–cost-based cost–effectiveness threshold: a panel discussion by Taylor & Francis Group

More episodes of the podcast Future Science Group

Trends, tools and transformation: the evolution of flow cytometry in bioanalysis 05/01/2026

115 analytes, one panel: a conversation on innovation in biomarker discovery 01/12/2025

Exploring biomarker testing in clinical research 03/11/2025

First void urine: revolutionizing potential non-invasive biomarker collection 27/10/2025

STEM Tea | Investing in our students 21/10/2025

LC–MS/MS for quantitation of protein biomarkers 14/10/2025

STEM Tea | Being visible as an act of service 14/10/2025

STEM Tea | Founding Black in Neuro 09/10/2025

STEM Tea | Disrupting racism and cisheteropatriarchy through research, pedagogy and mentorship in STEM education 02/10/2025

STEM Tea | Strengthening HBCUs 30/09/2025

Ver todos los episodios